New Delhi: The equity index fell for the third consecutive session on Thursday with BSE Sensex benchmarks falling more than 600 points dragged by losses in it and pharmaceutical shares.
30-share fell 634 points or 1.06 percent to close at 59,465; While the wider NSE settled 181 points or 1.01 percent lower at 17,800.
The top loser in the sensex package including Bajaj Finserv, Infosys, TCS, Sun Pharma and Hul with their shares fell by 4.57 percent.
Meanwhile, Power Grid, Bharti Airtel, Cat Asia and Maruti is the main enhancer.
On the NSE platform, sub-index Nifty, Pharma and FMCG fell 1.66 percent.
“The market can repair up to 17,500 after sharp run-up in a short time,” Samrat Dasgupta, CEO at Esquire Capital Investment Advisors told the Reuters news agency, referring to the level of Index Nifty 50.
With that company that reported a strong number of strong last week , investors will see the current bullet as a purchase opportunity, said Dasgupta, adding that investors will likely stay between the budget approach.
Beisdes, continued foreign capital from the Indian market also affected market sentiment, the traders said.
Foreign institutional investors (FIIS) are clean sellers in the capital market, because they sell shares worth Rs 2,704.77 Crore on Wednesday, according to the stock exchange data.
(With input from the agency)